DNA vaccines for SARS-CoV-2: toward third-generation vaccination era DOI
Vivek P. Chavda, Radhika Pandya, Vasso Apostolopoulos

и другие.

Expert Review of Vaccines, Год журнала: 2021, Номер 20(12), С. 1549 - 1560

Опубликована: Сен. 28, 2021

Introduction: Coronavirus outbreak 2019 (COVID-19) has affected all the corners of globe and created chaos to human life. In order put some control on pandemic, vaccines are urgently required that safe, cost effective, easy produce, most importantly induce appropriate immune responses protection against viral infection. DNA possess these features promising candidates for providing SARS-CoV-2.Area covered: Current understanding advances in toward COVID-19, especially those under various stages clinical trials.Expert opinion: Through vaccines, host cells momentarily transformed into factories produce proteins SARS-CoV-2. The system detects develop antibodies neutralize prevent This vaccine platform additional benefits compared traditional vaccination strategies like strong cellular response, higher safety margin, a simple production process as per cGMP norms, lack any infectious agent, robust large-scale production.

Язык: Английский

Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review DOI Creative Commons
David Julian McClements

Advances in Colloid and Interface Science, Год журнала: 2018, Номер 253, С. 1 - 22

Опубликована: Фев. 16, 2018

Язык: Английский

Процитировано

372

Enabling Technologies for Personalized and Precision Medicine DOI
Dean Ho, Stephen R. Quake,

Edward R.B. McCabe

и другие.

Trends in biotechnology, Год журнала: 2020, Номер 38(5), С. 497 - 518

Опубликована: Янв. 21, 2020

Язык: Английский

Процитировано

320

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems DOI Creative Commons
Tsvetelina Baryakova, Brett H. Pogostin, Róbert Langer

и другие.

Nature Reviews Drug Discovery, Год журнала: 2023, Номер 22(5), С. 387 - 409

Опубликована: Март 27, 2023

Poor medication adherence is a pervasive issue with considerable health and socioeconomic consequences. Although the underlying reasons are generally understood, traditional intervention strategies rooted in patient-centric education empowerment have proved to be prohibitively complex and/or ineffective. Formulating pharmaceutical drug delivery system (DDS) promising alternative that can directly mitigate many common impediments adherence, including frequent dosing, adverse effects delayed onset of action. Existing DDSs already positively influenced patient acceptability improved rates across various disease types. The next generation systems potential instate an even more radical paradigm shift by, for example, permitting oral biomacromolecules, allowing autonomous dose regulation enabling several doses mimicked single administration. Their success, however, contingent on their ability address problems made unsuccessful past. Improving recognized as one most impactful cost-effective improving general population. Here, Baryakova colleagues assess next-generation discuss impact had different

Язык: Английский

Процитировано

197

Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination DOI
Xiaoli Wei, Mara Beltrán‐Gastélum, Emil Karshalev

и другие.

Nano Letters, Год журнала: 2019, Номер 19(3), С. 1914 - 1921

Опубликована: Фев. 6, 2019

Vaccination represents one of the most effective means preventing infectious disease. In order to maximize utility vaccines, highly potent formulations that are easy administer and promote high patient compliance desired. present work, a biomimetic self-propelling micromotor formulation is developed for use as an oral antivirulence vaccine. The propulsion provided by magnesium-based core, cell membrane coating used detain neutralize toxic antigenic payload. resulting motor toxoids leverage their properties in more effectively elicit mucosal immune responses. After demonstrating successful fabrication toxoids, uptake shown vitro. When delivered mice via route, it then confirmed greatly improves retention material small intestine vivo. Ultimately, this translates into markedly elevated generation antibody titers against model toxin. This work provides proof-of-concept highlighting benefits active delivery vaccine development, opening door new set applications, which technology can provide significant benefits.

Язык: Английский

Процитировано

178

Materials for Immunotherapy DOI
C. Wyatt Shields, Liwen Wang, Michael A. Evans

и другие.

Advanced Materials, Год журнала: 2019, Номер 32(13)

Опубликована: Июнь 28, 2019

Abstract Breakthroughs in materials engineering have accelerated the progress of immunotherapy preclinical studies. The interplay chemistry and has resulted improved loading, targeting, release immunomodulatory agents. An overview that are used to enable or improve success immunotherapies studies is presented, from immunosuppressive proinflammatory strategies, with particular emphasis on technologies poised for clinical translation. organized based their characteristic length scale, whereby enabling feature each technology by structure material. For example, mechanisms which i) nanoscale can targeting infiltration payloads into tissues cells, ii) microscale facilitate cell‐mediated transport serve as artificial antigen‐presenting iii) macroscale form basis microenvironments promote cell reprogramming discussed. As a step toward establishing set design rules future immunotherapies, intrinsically activate suppress immune system reviewed. Finally, brief outlook trajectory these systems how they may be address unsolved challenges cancer, infectious diseases, autoimmunity presented.

Язык: Английский

Процитировано

172

Advances in Oral Drug Delivery Systems: Challenges and Opportunities DOI Creative Commons
Jie Lou,

Hongli Duan,

Qin Qin

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(2), С. 484 - 484

Опубликована: Фев. 1, 2023

The oral route is the most preferred for systemic and local drug delivery. However, delivery system faces harsh physiological physicochemical environment of gastrointestinal tract, which limits bioavailability targeted design system. Innovative pharmaceutical approaches including nanoparticulate formulations, biomimetic microfabricated devices have been explored to optimize targeting bioavailability. In this review, anatomical factors, biochemical physiology factors that influence delivering via are discussed recent advance in conventional novel improving ability highlighted. We also address challenges opportunities systems future.

Язык: Английский

Процитировано

170

Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria DOI
Yale Yue, Jiaqi Xu, Yao Li

и другие.

Nature Biomedical Engineering, Год журнала: 2022, Номер 6(7), С. 898 - 909

Опубликована: Май 2, 2022

Язык: Английский

Процитировано

156

Mucosal vaccines: Strategies and challenges DOI
Miao Li, Yi Wang,

Yuan Sun

и другие.

Immunology Letters, Год журнала: 2019, Номер 217, С. 116 - 125

Опубликована: Окт. 25, 2019

Язык: Английский

Процитировано

149

Vaccine delivery systems toward lymph nodes DOI

Yingyue Ding,

Zhaoting Li, Ana Jaklenec

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2021, Номер 179, С. 113914 - 113914

Опубликована: Авг. 4, 2021

Язык: Английский

Процитировано

126

Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies DOI Creative Commons
Raquel Cid, Jorge Bolı́var

Biomolecules, Год журнала: 2021, Номер 11(8), С. 1072 - 1072

Опубликована: Июль 21, 2021

To date, vaccination has become one of the most effective strategies to control and reduce infectious diseases, preventing millions deaths worldwide. The earliest vaccines were developed as live-attenuated or inactivated pathogens, and, although they still represent extended human vaccine types, also face some issues, such potential revert a pathogenic form formulations weaker immune response associated with vaccines. Advances in genetic engineering have enabled improvements design strategies, recombinant subunit vaccines, emerged, expanding number diseases that can be prevented. Moreover, antigen display systems VLPs those designed by nanotechnology improved efficacy Platforms for production evolved from first hosts,

Язык: Английский

Процитировано

121